In fact, the majority of mouse craniosynostosis models resulting from FGF signaling aberrations have been generated using activating mutations in FGF receptors, particularly Fgfr2 and Fgfr3 (Flaherty et al., 2016; Su et al., 2014). This evidence concerns the gene FGFR2 and craniosynostosis.